Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study

被引:0
|
作者
Dorinde M. van Andel
Jan J. Sprengers
Bob Oranje
Floortje E. Scheepers
Floor E. Jansen
Hilgo Bruining
机构
[1] University Medical Center Utrecht,Department of Psychiatry, Brain Center
[2] University Medical Center Utrecht,Department of Pediatric Neurology, Brain Center
[3] University of Amsterdam,Department of Child and Adolescent Psychiatry, Amsterdam UMC
来源
关键词
Tuberous sclerosis complex; Bumetanide; Open-label; NKCC1 antagonist; TAND; Irritability; ERP; Neurocognitive task;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
    van Andel, Dorinde M.
    Sprengers, Jan J.
    Oranje, Bob
    Scheepers, Floortje E.
    Jansen, Floor E.
    Bruining, Hilgo
    MOLECULAR AUTISM, 2020, 11 (01)
  • [2] Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study
    Juarez-Martinez, Erika L.
    van Andel, Dorinde M.
    Sprengers, Jan J.
    Avramiea, Arthur-Ervin
    Oranje, Bob
    Scheepers, Floortje E.
    Jansen, Floor E.
    Mansvelder, Huibert D.
    Linkenkaer-Hansen, Klaus
    Bruining, Hilgo
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [3] Immunoadsorption patients with multiple sclerosis:: an open-label pilot study
    Moldenhauer, A
    Haas, J
    Wäscher, C
    Derfuss, T
    Hoffmann, KT
    Kiesewetter, H
    Salama, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 523 - 530
  • [4] Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: A retrospective open-label trial
    Collins, James J.
    Tudor, Cynthia
    Leonard, Jennifer M.
    Chuck, Gail
    Franz, David Neal
    JOURNAL OF CHILD NEUROLOGY, 2006, 21 (01) : 53 - 57
  • [5] Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex
    Grayson, Leslie E.
    Peters, Jurriaan M.
    McPherson, Tarrant
    Krueger, Darcy A.
    Sahin, Mustafa
    Wu, Joyce Y.
    Northrup, Hope A.
    Porter, Brenda
    Cutter, Gary R.
    O'Kelley, Sarah E.
    Krefting, Jessica
    Stone, Scellig S.
    Madsen, Joseph R.
    Fallah, Aria
    Blount, Jeffrey P.
    Weiner, Howard L.
    Bebin, E. Martina
    PEDIATRIC NEUROLOGY, 2020, 109 : 39 - 46
  • [6] Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial
    Thiele, Elizabeth A.
    Bebin, E. Martina
    Filloux, Francis
    Kwan, Patrick
    Loftus, Rachael
    Sahebkar, Farhad
    Sparagana, Steven
    Wheless, James
    EPILEPSIA, 2022, 63 (02) : 426 - 439
  • [7] SIMVASTATIN IN SYSTEMIC SCLEROSIS PATIENTS - AN OPEN-LABEL STUDY
    Ionitescu, S. C.
    Mihai, C.
    Bojinca, M.
    Sfrent-Cornateanu, R.
    Ion, A.
    Macovei, L.
    Manea, O.
    Sasu, M.
    Ancuta, I.
    Milicescu, M.
    Mogosan, C.
    Abobului, M.
    Berghea, F.
    Predeteanu, D.
    Ionescu, R.
    Stoica, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S158 - S158
  • [8] Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis
    Chandrashekhar, Swathy
    Hamasaki, Anai C.
    Clay, Rebecca
    McCalley, Ayla
    Herbelin, Laura
    Pasnoor, Mamatha
    Jawdat, Omar
    Dimachkie, Mazen M.
    Barohn, Richard J.
    Statland, Jeffrey
    MUSCLE & NERVE, 2022, 66 (01) : 71 - 75
  • [9] BROMOCRIPTINE THERAPY IN MULTIPLE-SCLEROSIS - AN OPEN-LABEL PILOT-STUDY
    BISSAY, V
    DEKLIPPEL, N
    HERROELEN, L
    SCHMEDDING, E
    BUISSERET, T
    EBINGER, G
    DEKEYSER, J
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (05) : 473 - 476
  • [10] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
    Denton, C. P.
    Engelhart, M.
    Tvede, N.
    Wilson, H.
    Khan, K.
    Shiwen, X.
    Carreira, P. E.
    Gonzalez, F. Diaz
    Black, C. M.
    van den Hoogen, F. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) : 1433 - 1439